532. Establishing a SARS-CoV-2 Monoclonal Antibody Infusion Clinic: Early Trends in Outcomes and Disparities

BACKGROUND: SARS-CoV-2 monoclonal antibodies (SMA) have demonstrated efficacy in treatment of early, mild to moderate COVID-19 in patients at high risk for progression to severe COVID-19. We created an SMA infusion clinic at a large, urban academic medical center using both internal and community-ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Hare, Allison J, Rivera McPhaul, Judith M, Cargan, Patrick, Tebas, Pablo, Degnan, Kathleen, Baron, Jillian T, Hamilton, Keith W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643715/
http://dx.doi.org/10.1093/ofid/ofab466.731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643715/
http://dx.doi.org/10.1093/ofid/ofab466.731

Ejemplares similares